Back to search
Scientific Name: Trilaciclib
Brand Name: Cosela
Company Owner: Not Available
Mechanism Of Action Trilaciclib is inhibits cyclin-dependant kinase 4 (CDK4) at a concentration of 1 nmol/L and cyclin-dependent kinase 5 (CDK5) at 4 nmol/L.
Description of the Drug: Trilaciclib is a CDK4 and CDK6 inhibitor to reduce the risk of chemotherapy induced myelosuppression.
Protein Data Bank: Not Available
Source: DrugBank Online – Retrieved 2023-01-23 from